This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Timing bond allocations can reduce risk and stabilize income in retirement. Learn indicators and phased approaches to use bonds effectively.
22,161 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
The U.S. Treasury’s latest report signals a nuanced path for crypto privacy within regulated markets, hinting at supe...
CoinFello debuts OpenClaw Skill, enabling Moltbots to perform on-chain actions through narrowly scoped delegations wh...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
A prominent chart analyst points to a long-term XRP pattern suggesting a dramatic upside in the next market cycle. Tr...
Federal officials order a Texas-based oil company to resume offshore California production under the Defense Producti...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
The trending meme coin Pippin shed roughly half of its value in 24 hours, triggering a split among traders between fe...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
A nationwide recall has been issued for nearly 90,000 bottles children's ibuprofen after reports of contamination. Fa...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
As SpaceX moves closer to a historic IPO, investors are eyeing space peers for immediate upside. This report highligh...